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Abstract
Candida albicans is an opportunistic oral pathogen. The flexibility of this microorganism in response to environmental changes includes
the expression of a cyanide-resistant alternative respiratory pathway. In the present study, we characterized both conventional and alternative
respiratory pathways and determined their ADP/O ratios, inhibitor sensitivity profiles and the impact of the utilization of either pathway on
susceptibility to commonly used antimycotics. Oxygen consumption by isolated mitochondria using NADH or malate/pyruvate as respiratory
substrates indicated that C. albicans cells express both cytoplasmic and matrix NADH–ubiquinone oxidoreductase activities. The ADP/O
ratio was higher for malate/pyruvate (2.2F0.1), which generate NADH in the matrix, than for externally added NADH (1.4F0.2). In
addition, malate/pyruvate respiration was rotenone-sensitive, and an enzyme activity assay further confirmed that C. albicans cells express
Complex I activity. Cells grown in the presence of antimycin A expressed the cyanide-insensitive respiratory pathway. Determination of the
respiratory control ratio (RCR) and ADP/O ratios of mitochondria from these cells indicated that electron transport from ubiquinone to
oxygen via the alternative respiratory pathway was not coupled to ATP production; however, an ADP/O ratio of 0.8 was found for substrates
that donate electrons at Complex I. Comparison of antifungal susceptibility of C. albicans cells respiring via the conventional or alternative
respiratory pathways showed that respiration via the alternative pathway does not reduce the susceptibility of cells to a series of clinically
employed antimycotics (using FungitestR), or to the naturally occurring human salivary antifungal peptide, histatin 5.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
ATP formation in respiring organisms is coupled to
electron flow from reduced substrates through the respira-
tory chain to a terminal electron acceptor. In vertebrates,
this pathway is cyanide-sensitive and involves NADH–
ubiquinone (Q) oxidoreductase (Complex I), cytochrome
bc1 (Complex III) and cytochrome oxidase (Complex IV)
as proton translocating oxidoreductases [1]. While in
vertebrates, the respiratory chain complexes and the path-
way of electron transport appear to be highly conserved,
those of plants and fungi are more complex and flexible in
nature [2]. Extensive research, particularly in the area of
plant respiration, has led to the characterization of some of
these alternative systems that include alternative NADH-Q
oxidoreductases and alternative terminal oxidases (AOX)
[3–5].
In mammals, the only known NADH-Q oxidoreductase
is Complex I [6]. The active center of this complex is facing
the mitochondrial matrix and is composed of at least 43
distinct subunits [6,7], at least five iron–sulfur clusters and
a noncovalently bound FMN molecule [8]. In contrast to
mammals, plants, fungi and bacteria contain other types of
NADH-Q oxidoreductases that are distinct from Complex I
[4]. Alternative NADH-Q oxidoreductases catalyze the
same redox reaction as Complex I, but do not contribute
to the generation of a transmembrane proton gradient and
are rotenone-insensitive. In some microorganisms such as
Saccharomyces cerevisiae and Saccharomyces carlsbergen-
sis, Complex I is absent [9,10] and three alternative mito-
chondrial NADH-Q oxidoreductases transfer electrons from
NADH to ubiquinone [3,4]. One of these faces the matrix
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while the others face the cytoplasm and compensate for the
absence of the malate/aspartate shuttle in this microorgan-
ism [11]. Unlike Complex I, alternative NADH-Q oxidor-
eductases, e.g. in S. cerevisiae, are single polypeptides of 53
or 58 kDa (external and internal NADH-Q oxidoreductase,
respectively) and are devoid of iron–sulfur centers [11].
In addition to alternative NADH-Q oxidoreductases, it
has been well established that higher plants, some fungi and
protozoa can also express an alternative oxidase (AOX) that
is reduced by electrons from the ubiquinol pool [12]. While
AOX is biochemically consistent with a terminal oxidase, as
it reduces oxygen to water, it is distinguished by its
insensitivity to cyanide and antimycin A and its sensitivity
to hydroxamic acids such as salicyl hydroxamic acid
(SHAM) [3,5]. The nuclear encoded AOX found in most
fungi (with the exception of S. cerevisiae and Schizosac-
charomyces pombe) is 32–40 kDa in size, and indirect
evidence suggests the presence of two iron centers [5].
While plant AOX differs from fungal AOX in its structure
and allosteric control, both are induced by respiratory chain
inhibitors that act downstream from coenzyme Q, or by
oxidative stress, suggesting a universal role for AOX in
plant and fungi in the protection against oxidative damage
[13–18].
Research into fungal alternative respiration has been
limited compared to plant alternative respiration, not only
in terms of function but also in terms of identification of the
respiratory chain components and their contributions to ATP
formation. One species that has not been much investigated
in this respect but is of considerable clinical importance is
Candida albicans. C. albicans is a common resident of the
human gastrointestinal tract that causes infections in immu-
nocompromised patients [19]. It has long been known that
alternative cyanide-insensitive respiration can be induced in
Candida species [20–22], including C. albicans, upon
ageing of cells [23] or upon exposure of cells to antimycin
A or sodium cyanide [24]. Recently, Huh et al. [25,26]
demonstrated that AOX in C. albicans is encoded for by
two, tandemly arranged genes, designated AOX1a and
AOX1b, encoding polypeptides of 379 and 365 amino acids,
respectively. While AOX1a is constitutively expressed in
low amounts, AOX1b expression is dependent on growth
phase and can be induced by cytochrome oxidase inhibitors
[26]. Only double knockout mutants of AOX1b are incapa-
ble of cyanide-insensitive respiration, indicating that this
gene product confers cyanide-insensitive respiration in C.
albicans [26].
Even though cyanide-insensitive respiration in C. albi-
cans has been established and the genes responsible for the
expression of the component(s) of this pathway have been
identified, physiological characterization of the conven-
tional and alternative respiratory pathways on a mitochon-
drial level is sparse [24,27]. In the present study, we applied
conditions where either the conventional or the alternative
pathway was active in C. albicans and used a combination
of substrates, inhibitors and enzyme activity assays to
investigate the contribution of the various redox systems
to respiration and ATP formation. In addition, since expres-
sion of the alternative pathway occurs not only in response
to antibiotics but also upon ageing of cells, conditions that
are relevant in sites of Candida infection, the potential
clinical implication of AOX induction in C. albicans was
investigated by comparing antifungal susceptibility and
germ tube formation in cells expressing either pathway.
2. Materials and methods
2.1. C. albicans growth conditions and spheroplast for-
mation
C. albicans (ATCC 10231) was grown from Sabouraud
dextrose agar (Difco, Detroit, MI) into Sabouraud dextrose
broth (Difco)F10 AM antimycin A (Sigma, St. Louis, MO).
After 16 h incubation, cells were subcultured 1:400 and
early log phase cells were harvested 5 h later by centrifu-
gation. Stationary phase cells were collected after 48 h
incubation in Sabouraud dextrose broth. The pellets were
washed in milliQ water and suspended in 1 ml buffer (50
mM Tris–HCl, pH 7.5, 10 mM MgCl2 and 1.4 M sorbitol)
per gram yeast pellet and treated with the h-1-3 glucanase
zymolyase 100 T (Seikagaku America, Falmouth, MA) to
form spheroplasts [28].
2.2. Isolation of mitochondria
Mitochondria were isolated from C. albicans spheroplasts
as described previously [28]. In brief, C. albicans sphero-
plasts were collected by centrifugation (1000g at 4 jC) and
homogenized for 5 min on ice in 0.4 M sorbitol, 0.2% (w/v)
bovine serum albumin (BSA; fraction V, Sigma) and 10 mM
imidazole (pH 6.4) (Fisher, Fair Lawn, NJ), using a manual
Potter-Elvehjem homogenizer. The homogenate was diluted
with 1 vol. 1 M sorbitol, 25 mM KH2PO4, 4 mM EGTA
(Sigma), 0.2% (w/v) BSA, and 10 mM imidazole (pH 6.4)
and debris was pelleted by centrifugation (5 min at 1000g at
4 jC). The supernatant was removed and mitochondria were
pelleted by centrifugation (10 min at 12,000g at 4 jC). The
reddish pellet containing the mitochondria was suspended in
0.6 M mannitol, 2 mM EGTA, 0.2% (w/v) BSA, and 10 mM
imidazole (pH 6.4), to an OD620 of f15, and kept on ice.
Protein concentrations in mitochondrial preparations were
determined using the bicinchoninic acid (BCA) method with
BSA as a standard [29]. S. cerevisiae mitochondria were
isolated from wild type strain CEN.PK2-1C (MATa. Ura3,
his3, leu2, trp1) [30] as described [31].
2.3. Measurement of oxygen consumption
Oxygen consumption was measured using a biological
oxygen monitor model 5300 equipped with a 5331 standard
oxygen probe (Yellow Springs Instruments, Ohio, USA) or
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a Rank Brothers oxygen electrode and vessel (Rank Broth-
ers, Bottisham, Cambridge, England). All experiments were
performed at 30 jC in air-saturated buffer. Blastoconidia
were suspended in 1 mM potassium phosphate buffer (pH
7.0) to an OD620 of 1.7F0.2. Spheroplasts were suspended
in 1.2 M sorbitol, or 1.2 M sorbitol containing Sabouraud
dextrose broth (30 g/l), to an OD620 of 1.7F0.2. Mitochon-
dria were suspended in respiration buffer (0.65 M mannitol,
2 mM MgCl2, 16 mM KH2PO4, 10 mM imidazole (pH 6.4))
to an OD620 of 0.15F0.05. This buffer does not contain
BSA, and therefore AOX activity might be slightly under-
estimated due to inhibition of AOX by free fatty acids [32].
State 2, State 3 and State 4 respiratory rates were determined
as described previously [2], using either 1 mM NADH
(Sigma), 10 mM potassium succinate (Sigma) or a mixture
of 2 mM malate (Sigma) and 10 mM pyruvate (Sigma), as
respiratory substrates. ADP (Sigma) was used at a final
concentration of 0.33 mM. For ADP/O ratio determination,
the ADP concentration was determined from the absorbance
at 259 nm (e=15.4103 M1 cm1) and the consumed
nanomoles of oxygen were determined based on the sol-
ubility of oxygen in buffered mitochondrial medium at 30
jC of 445 nmol O per milliliter [33]. The respiratory rates
before addition of ADP (State 2), during phosphorylation
(State 3) and after depletion of ADP (State 4) were used to
calculate the ACR (State 3/State 2), the RCR (State 3/State
4) and ADP/O ratio.
2.4. NADH dehydrogenase activity assay
Mitochondria from C. albicans or S. cerevisiae (10 and
35 mg protein/ml, respectively) were freeze-thawed once,
collected by centrifugation (16,000g for 5 min at 25 jC)
and diluted 10-fold in cold milliQ water. Mitochondria
were homogenized (320 s at 13,000 rpm/min on ice) in
an Ultra-turrax T 25 basic blender (IKA-Werke, Staufen,
Germany) to disrupt the membranes. Disrupted mitochon-
drial preparations were collected by centrifugation (5 min at
16,000g at 25 jC) and suspended in 0.6 M mannitol, 2
mM EGTA, 0.2% (w/v) BSA, and 10 mM imidazole (pH
6.4) to approximately 5 mg protein/ml. NADH dehydro-
genase activity in C. albicans or S. cerevisiae mitochon-
drial preparations (final concentrations 77 and 11 Ag
protein/ml, respectively) was determined by measurement
of NADH oxidation at 340 nm (e=6.22103 M1 cm1) in
buffer containing 250 mM sucrose (BDH laboratory sup-
plies, England), 1 mM EDTA (BDH), 50 mM Tris–HCl
(Sigma), pH 7.4, 300 nM antimycin A (Sigma), 2 mM
KCN (Fluka Chemie, Buchs, Switzerland), 0.15 mM
Coenzyme Q1 (Sigma), and 0.1 mM NADH (Sigma).
Rotenone (Sigma) was used at a final concentration of 10
Ag/ml.
2.5. Antifungal susceptibility testing
C. albicans cells were grown directly from the ATCC
stock (10231) onto Sabouraud dextrose agar (Difco) for 48 h
at 30 jC. Cells were cultured in triplicate in 100 ml
Sabouraud dextrose F10 AM antimycin with each culture
derived from a different colony. After 16-h incubation, each
culture was subcultured 1:400 in 100 ml Sabouraud Dex-
trose Broth, and incubated for 5 h until the cells reached the
logarithmic growth phase. Cells were then collected by
centrifugation (5 min at 6000g at 4 jC) and suspended
in milliQ water to an OD620 of 0.47 (which approximates
2.5 McFarland units). Antifungal susceptibility was assessed
with FungitestR (BioRad, Marnes La Coquette, France)
according to the manufacturer’s instructions, but with a
slightly higher inoculum density as proposed by Davey et
al. [34]. FungitestR includes six antifungal agents, each at
two concentrations: amphotericin B (2 and 8 Ag/ml), 5-
fluorocytosine (2 and 32 Ag/ml), fluconazole (8 and 64 Ag/
ml), itraconazole and ketoconazole (0.5 and 4 Ag/ml) and
miconazole (0.5 and 8 Ag/ml). The sensitivity of the cells to
the oral antifungal peptide, histatin 5 [35] was investigated
Fig. 1. Induction of the alternative respiratory pathway in C. albicans.
Oxygen consumption was measured with an oxygen electrode at 30 jC.
Spheroplasts from log phase C. albicans cells were suspended in 1.2 M
sorbitol (nutrient-free buffer, dashed line) or in 1.2 M sorbitol containing
Sabouraud dextrose broth (30 g/l, nutrient-rich buffer, solid line), final
OD620 1.7, sodium cyanide (0.66 mM) or SHAM (5 mM) were added
where indicated.
Fig. 2. Respiration by log phase C. albicans cells grown in the absence (A)
or presence (B) of antimycin A. C. albicans were grown to log phase in
Sabouraud dextrose brothFantimycin A (10 AM). Oxygen consumption of
cells suspended in 1 mM potassium phosphate (pH 7.0), OD620 1.7, was
measured with an oxygen electrode at 30 jC. Where indicated, sodium
cyanide (0.66 mM) and SHAM (5 mM) were added.
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in a killing assay essentially as previously described [36]. In
brief, log phase cells grown in Sabouraud dextrose broth
F10 AM antimycin A were washed in milliQ water, sus-
pended in 1 mM potassium phosphate buffer (pH 7.0), and
exposed to various concentrations of histatin 5 (American
Peptide Company, Sunnyvale, CA) for 1.5 h at 37 jC. Cell
viability was assessed by colony formation on Sabouraud
Dextrose Agar after 48 h incubation at 30 jC.
2.6. Induction of germ tube formation
In Sabouraud dextrose broth, C. albicans grow as blas-
toconidia. To induce the formation of germ tubes, logarith-
mic phase C. albicans blastoconidia, expressing the
conventional or the alternative respiratory pathway, were
suspended in horse serum (Sigma) for 3 h at 37 jC.
Germination was assessed qualitatively by light microscopy.
3. Results
3.1. Induction of the alternative respiratory pathway under
non-growth conditions
The alternative respiratory chain in C. albicans is
induced by inhibitors such as antimycin A and cyanide,
which inhibit cytochromes bc1 and aa3, respectively [24].
To verify the inducibility of this pathway in the ATCC
10231 C. albicans strain, blastoconidia or spheroplasts were
suspended in nutrient-free buffer, or in nutrient-rich buffer
(Fig. 1). In both nutrient-free and nutrient-rich buffers, C.
albicans spheroplasts respired at similar rates, indicative of
respiration on intracellular energy stores. After 5-min incu-
bation, cyanide, an inhibitor of cytochrome oxidase, was
added, which abolished respiration in both buffers. In the
nutrient-rich buffer, the alternative, cyanide-insensitive res-
piratory chain was induced within 10–20 min, and respira-
tory rates 50F6% (n=4) of the original respiratory rate were
reestablished. This respiration was inhibited by salicylhy-
droxamic acid (SHAM), a specific inhibitor of the alter-
native respiratory pathway [37]. The alternative pathway
could not be induced in nutrient-free medium.
3.2. Induction of the alternative respiratory pathway under
growth conditions
To investigate further the alternative respiratory path-
way, cells were grown to log phase in the presence of 10
AM antimycin A and compared with control cells grown in
the absence of antimycin A (Fig. 2). The respiratory rates
of log phase cells grown with or without antimycin A were
comparable (27F7.0 and 33F1.0 nmol O/min/OD620,
respectively). However, the percent cyanide sensitivities
were quite different, 1.7F2.5% and 99F1% inhibition,
respectively. Respiration by control cells was insensitive
to SHAM (Fig. 2A) while respiration by cells grown in the
presence of antimycin was almost completely inhibited by
SHAM (Fig. 2B). The insensitivity of the antimycin-grown
cells to cyanide in the absence of SHAM indicated that the
alternative pathway is the only pathway utilized. Likewise,
it can be concluded from results in Fig. 2A that log phase
cells grown in the absence of cyanide only respire through
the cytochrome oxidase pathway. In contrast to log phase
control cells, the respiration of stationary phase control
cells was largely resistant to cyanide (11.6F0.9% inhib-
ition of respiration by cyanide). These findings are in
accordance with previous reports showing that ageing of
C. albicans cultures induces alternative respiration [23] and
that under these conditions, both respiratory pathways
coexist (Ref. [23] and Helmerhorst et al., unpublished
observations).
Fig. 3. Respiratory activity of mitochondria isolated from C. albicans
grown in the absence (A) or presence (B) of antimycin A. Mitochondria
were suspended in respiration buffer (OD620 0.15) and oxygen consumption
was measured by an oxygen electrode at 30 jC. Where indicated, malate/
pyruvate (M+P, 2 and 10 mM, respectively), ADP (0.33 mM), or SHAM (5
mM) were added.
Table 1
ACR, RCR, and ADP/O values of mitochondria respiring through the conventional and alternative respiratory pathway
Conventional pathway Alternative pathway
Substrate ACRa RCRb ADP/O Substrate ACR RCR ADP/O
NADH 2.1F0.2c 2.4F0.2 1.4F0.2 NADH n.d.d n.d.d 0
Succinate 2.4F0.1 1.6F0.1 1.4F0.2 Succinate n.d.d n.d.d 0
Mal+Pyr 3.3F0.5 2.3F0.3 2.2F0.1 Mal+Pyr 1.6F0.2 1.3F0.1 0.8F0.1
a ACR, acceptor control ratio, ratio of the respiratory rates in State 3/State 2.
b RCR, respiratory control ratio, ratio of the respiratory rates in State 3/State 4.
c Values represent the meanFS.D. (n> 4).
d When no increase in respiration was observed upon addition of ADP, ACR and RCR values did not apply (n.d., not determined).
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3.3. Properties of mitochondria expressing the conventional
or the alternative respiratory pathway
To study the properties of mitochondria in which either
the conventional or the alternative respiratory pathway was
active, cells were grown to log phase in broth with or
without antimycin A. Oxygen consumption by isolated
mitochondria was assessed using malate/pyruvate as the
respiratory substrates. They generate NADH within the
mitochondrial matrix (Fig. 3), which donates electrons to
an NADH-Q oxidoreductase facing the matrix. Both cya-
nide-sensitive (Fig. 3A) and cyanide-resistant (Fig. 3B)
mitochondria oxidized malate/pyruvate, and, upon addition
of ADP, respiratory control was observed. Both cyanide-
sensitive and cyanide-insensitive mitochondria also oxi-
dized NADH, which cannot cross the mitochondrial inner
membrane, indicating NADH-Q oxidoreductase activity
facing the cytoplasmic side (Table 1). From a series of
experiments (n>4), the RCR and ADP/O ratios were deter-
mined for cyanide-sensitive and cyanide-resistant mitochon-
dria using various respiratory substrates (Table 1). Typical
respiratory rates observed with mitochondria from control
cells and antimycin-grown cells were 470 and 170 nmol O/
min/mg protein, respectively, when NADH was the sub-
strate. Respiratory rates using NADH, succinate or malate/
pyruvate as substrates were generally in the proportion of
2:1:1. Mitochondria from control cells showed significantly
higher ACR values with malate/pyruvate than with NADH
or succinate. Also, ADP/O values were significantly higher
for malate/pyruvate (2.2F0.1) than for NADH (1.4F0.2) or
succinate (1.4 F 0.2). Cyanide-insensitive mitochondria did
not exhibit respiratory control (ACRf1) when either
NADH or succinate was the substrate. In contrast, with
malate/pyruvate, ACR and RCR values were 1.6F0.2 and
1.3F0.1, respectively, and the ADP/O value was 0.8 (Table
1), showing that phosphorylation occurs under these con-
ditions.
3.4. Complex I activity in C. albicans mitochondria
The ADP/O ratios represented in Table 1 indicate that in
both cyanide-sensitive and cyanide-resistant C. albicans
mitochondria oxidation of malate/pyruvate forms more
ATP than oxidation of external NADH, suggestive of
Complex I proton pumping. This was supported by the
observation that malate/pyruvate respiration was almost
completely inhibited by rotenone, whereas respiration on
external NADH or succinate was insensitive to rotenone
(Table 2). Similarly, mitochondria from cells grown in the
presence of antimycin A were rotenone sensitive (data not
shown). To assess whether Complex I activity was growth
phase dependent, as is the case in the related species C. utilis
[38,39], mitochondria were also isolated from stationary
phase C. albicans cells grown in the absence of antimycin
A. While mitochondria isolated from stationary phase C.
albicans, like intact stationary phase blastoconidia, had
gained cyanide-resistance, they remained sensitive to rote-
none (Table 2).
NADH-Q oxidoreductase activity in log phase C. albi-
cans mitochondria was assessed directly in an enzyme
assay, using disrupted mitochondria, thus exposing both
internal and external NADH-Q oxidoreductases to NADH.
This showed that NADH oxidation could be partly inhibited
by 10 Ag/ml rotenone (Fig. 4), a concentration that is
sufficient to completely inhibit NADH oxidation in beef
heart mitochondria [40]. Increase in the rotenone concen-
tration did not further inhibit C. albicans NADH-Q oxidor-
eductase activity (data not shown). NADH oxidation by
disrupted S. cerevisiae mitochondria, which lack Complex I
[9–11], was insensitive to rotenone (Fig. 4). These obser-
vations, together with the data from Tables 1 and 2, are
further support for a matrix-facing NADH-Q oxidoreductase
in log phase C. albicans that is a rotenone sensitive proton
pump similar to Complex 1. Rotenone inhibition of dis-
rupted mitochondria from C. albicans was 70F10%, sug-
gesting that when all NADH-Q reductases are equally
Table 2
Rotenone sensitivity of mitochondria isolated from log phase and stationary
phase C. albicans cells
Respiratory substrate Log phase
mitochondria
Stationary phase
mitochondria
NADH 108.0F1.6a n.d.
Malate+pyruvate 4.2F3.3 4.1F4.1
Succinate 97.0F5.1 n.d.
a Values are expressed as percentage of State 2 respiration, prior to the
addition of rotenone, and represent the meanFS.D. of three measurements.
Fig. 4. NADH-Q oxidoreductase activity in disrupted mitochondria of C.
albicans (C. alb., upper graphs) and S. cerevisiae (S. cer., lower graphs).
Mitochondrial membranes were suspended to 77 and 11 Ag/ml, respec-
tively, in enzyme buffer containing 0.1 mM NADH at 30 jC. Oxidation of
NADH was initiated by addition of coenzyme Q1 (CoQ, 0.15 mM) and
followed spectrophotometrically at 340 nm. Rotenone (10 Ag/ml) was
added were indicated. Consumption of NADH is expressed as DAmol
NADH/min/mg protein.
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accessible to the same concentration of NADH, most
oxidation occurs via the rotenone-sensitive pathway.
3.5. Influence of the mode of cellular respiration on
susceptibility to antifungal agents
As C. albicans is an important opportunistic infective
agent in humans [19], we investigated whether expression
of the alternative respiratory pathway influenced its sensi-
tivity to clinically employed antimycotics. Cells were grown
to log phase in broth with or without antimycin A. The
sensitivity of each culture to 5-fluorocytosine, amphotericin
B, fluconazole, ketoconazole, itraconazole and miconazole
was assessed with a commercial assay (FungitestR, Bio-
Rad). The assay is based on a microdilution method in
RMPI 1640 medium supplemented with a redox indicator.
Reduction of the indicator by growing cells, which turns the
medium from purple to pink, was observed with all growth
controls. Comparison of the results revealed no differences
in sensitivity between C. albicans respiring through the
conventional or the alternative respiratory pathways. Both
cultures, each tested in triplicate, were inhibited by all six
antifungal agents included in the assay, as indicated by the
absence of a color change of the growth-indicator (data not
shown).
Since C. albicans is a common resident of the human
oral cavity [35,36], it was also of interest to investigate
whether expression of the alternative respiratory pathway
influenced its sensitivity to naturally occurring salivary
antifungal proteins. Histatin 5 is a small cationic peptide
present in human saliva that exerts strong fungicidal activity
against C. albicans and other fungal species [35,41]. Results
obtained after exposure of cells expressing the cyanide-
sensitive or the cyanide-resistant pathway to histatin 5
indicated that there are no marked differences in sensitivity
between both cultures for this peptide (Fig. 5).
4. Discussion
The present study was undertaken to elucidate the con-
stitution of the respiratory chains in the human pathogen C.
albicans using the classical method of ADP/O determination
and selective respiratory chain inhibitors, together with
enzyme inhibition assays. The data obtained, together with
earlier studies on partly uncoupled C. albicans mitochondria
[24,27] and on whole C. albicans cells [23], allowed us to
construct a model for the various respiratory chains in C.
albicansmitochondria (Fig. 6). Our data support the presence
of a rotenone-sensitive and proton-pumping NADH-Q oxi-
doreductase similar to Complex I, as well as an alternative,
external rotenone-insensitive NADH-Q oxidoreductase.
Rotenone-sensitivity was independent of the growth
phase of the cells and appeared to be the only active internal
NADH-Q oxidoreductase in this species. If cells respire via
the alternative, cyanide-insensitive respiratory pathway,
Complex I is the only site where proton pumping can occur,
since the activity of AOX is not associated with proton
translocation. Flow of electrons through an alternative
NADH-Q oxidoreductase and AOX would therefore theo-
retically lead to no proton pumping and thus to no mito-
chondrial ATP synthesis. Although there is evidence that
respiration without proton pumping may serve an important
biological purpose [42], no fungi are known in which
Complex I is absent and AOX is present [3]. Therefore,
the observed Complex I activity in C. albicans mitochondria
expressing AOX (from antimycin A grown cells and from
stationary phase cells) was expected. In contrast to C. utilis
[38,39], we found that Complex I was also active in log
phase C. albicans cells, and, thus, that it is expressed in
conjunction with either AOX or with cytochromes bc1 and
aa3.
In addition to Complex I, C. albicans cells express ex-
ternal NADH-Q oxidoreductase activity. C. albicans may
contain only one external alternative NADH-Q oxidoreduc-
tase, like the yeast Yarrowia lipolytica [4], but we cannot
exclude the possibility that several external alternative
NADH-Q oxidoreductases are present, as is the case in S.
cerevisiae [3,4]. Complex I activity in C. albicans shows
that the genes for Complex I in this species (Ref. [43] and C.
albicans genome sequence data available to date (http://
www-sequence.stanford.edu/group/candida/index.html) are
expressed and functional. The C. albicans genome further-
more contains at least three genes, YMR145, YMX6 and
NDI1, which show a high degree of similarity to the
conserved nucleotide binding domains in S. cerevisiae
alternative NADH-Q oxidoreductase genes SCNDI1,
SCNDE1 and SCNDE2. Future studies should elucidate
Fig. 5. Susceptibility of cells respiring through the conventional and
alternative pathway to histatin 5. C. albicans cells were grown to log phase
in the absence and presence of antimycin A (10 AM), suspended in 1 mM
potassium phosphate pH 7.0 (OD620=0.4) and exposed for 1.5 h to various
concentrations of histatin 5. Viability was determined by colony counting
48 h after plating of the cells on agar. White bars, cyanide-sensitive cells,
grey bars, cyanide-resistant cells. Represented are the meansFS.D. of two
experiments performed in duplicate.
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the localization and functions in C. albicans of the YMR145,
YMX6 and NDI1 gene products in more detail.
When C. albicans cells were grown in the presence of
antimycin A, cyanide-insensitive AOX activity was in-
duced. In accordance with previous studies on AOX from
a variety of species [12], AOX in C. albicans did not
contribute to ATP synthesis, since oxidation of external
NADH or succinate, which donate electrons downstream
from Complex I, was not coupled to ATP formation. The
observed ADP/O ratios were 2.2 for electrons passing
through Complexes I, III, and IV, 1.4 for electrons passing
through Complexes III and IV, and 0.8 for electrons passing
through Complex I and AOX. These values are in agree-
ment with theoretical values of an ADP/O ratio of 2.5 for
the full conventional respiratory chain (10 H+ pumped, with
4 H+/ATP molecule), 1.5 for external NADH-Q oxidore-
ductase in conjunction with cytochrome oxidase, and 1.0 for
Complex I alone [44].
Respiration via AOX is clearly less efficient than respi-
ration via the conventional chain. Since only one proton
pumping complex is involved (Complex I), 1 ATP is formed
compared to 2.5 when the conventional respiratory pathway
is used. Thus, alternative respiration operates at a consid-
erable energy cost, and much of this is lost as heat. While in
Araceae, the function of AOX in thermogenic inflorescence
is possibly related to heat production [12], it seems unlikely
that heat production is a major function of AOX in uni-
cellular microorganisms. With respect to the low energy
conservation, alternative respiration has been compared to
other energy dissipating mechanisms in the respiratory
chain, such as natural uncoupler proteins [12,32]. One
potential role for uncoupled respiration in general is to
facilitate glycolytic ATP production by acting as a sink for
cytoplasmic NADH formed during fermentation under con-
ditions of excess of nutrient availability [45]. However,
since AOX is present in plants and also in strictly aerobic
yeasts such as C. parapsilosis [22], it is unlikely that this is
the major function of AOX. A third and attractive possible
role of uncoupled respiration is to protect cells from super-
oxide radical formation by preventing excessive reduction
of the Q-pool [42]. Indeed, in both plant and fungi,
expression of AOX can be induced by inhibition of the
conventional respiratory pathway, presumably leading to an
increase in the Q reduction level and in oxygen radical
production, but also by externally applied oxidative stress
conditions [14,17,18] or by salicylate, an inhibitor of
catalase [17,18]. In addition, antisense suppression of
AOX expression in transgenic tobacco cells significantly
increases ROS levels whereas overexpression of AOX
lowers ROS levels [13]. Based on these observations, it
has been postulated that the predominant and universal role
of AOX in plant as well as in fungal cells might be the
protection against oxygen radical formation by lowering the
Q-redox poise.
Apart from the importance of the physiological role of
AOX in unicellular microorganisms such as C. albicans, it
was of interest to investigate the clinical consequence of
AOX expression in this microorganism since it constitutes
an important human opportunistic pathogen [19,41]. AOX
expression by C. albicans in vivo has yet to be elucidated;
however, it is anticipated that in the oral cavity where C.
albicans is a resident, substrate limitation, growth in oral
biofilm or at sites of infections may create stress conditions
that induce alternative respiration. Therefore, we studied if
AOX expression would influence antifungal susceptibility
and germ tube formation. The latter is considered to be
related to adhesion and invasive growth and therefore an
important virulence factor [46]. A commercial antifungal
susceptibility test was chosen with three possible outcomes
(susceptible, intermediate, or resistant) to identify clinically
Fig. 6. Diagram of the alternative (A) and conventional (B) respiratory chain in C. albicans mitochondria. The matrix-facing NADH-Q oxidoreductases
contains Complex I type characteristics, such as rotenone sensitivity, and proton pumping. Evidence for an internal, rotenone-insensitive NADH-Q
oxidoreductase could not be deduced from the data obtained. C. albicans contains at least one external alternative NADH dehydrogenase, but the presence of
additional external NADH dehydrogenases cannot be excluded. The alternative oxidase (AOX) branches off from the conventional respiratory chain at the
Coenzyme Q level. Indicated are the sites of inhibition of rotenone, antimycin A, cyanide and SHAM, the sites of entry of NADH and succinate and the sites of
proton pumping (*).
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important differences rather than to identify small differ-
ences in susceptibility that would have little clinical rele-
vance. The tests indicated no differences in susceptibility,
and thus no differences in response to clinical treatment are
to be expected if cells change their expression levels of
AOX. Likewise, AOX expression did not alter the suscept-
ibility to the natural salivary peptide histatin 5, nor did it
enhance germ tube formation (data not shown), indicating
that there are no marked differences in virulence between
cells expressing the conventional or the alternative respira-
tory pathway.
This study shows that C. albicans contains a variety of
respiratory systems whose expression depends on growth
conditions. Future study should elucidate in more detail the
factors that regulate the expression of the individual com-
plexes and the partitioning of electrons between both
respiratory chains, and the contribution of this flexible
adaptation in the successful establishment of C. albicans
in complex microbial ecological systems and on its survival
under conditions of oxidative stress.
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